Latest News and Press Releases

AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute Dans les études de phase 3 COAST 1, COAST 2 et SHORE,...

AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed...

  This is a joint press release by Keurig Dr Pepper Inc., Kodiak BidCo B.V. and JDE Peet’s N.V. pursuant to the provisions of Section 16, paragraph 1 and 2, Section 17, paragraph 1 and Section 4,...

Toronto, ON, March 27, 2026 (GLOBE NEWSWIRE) -- Introduction – What Is Rastuxor? Rastuxor is presented as a modern digital trading platform engineered to deliver structured market access through a...

Miami, Florida, March 27, 2026 (GLOBE NEWSWIRE) -- The Arm Confidence Problem That Nobody Talks About There is a conversation happening in dressing rooms, group chats, and doctors' offices...

New York City, NY, March 27, 2026 (GLOBE NEWSWIRE) -- Something interesting is happening in the way Americans deal with foot pain. Instead of booking another $250 podiatrist appointment or...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with...

Confirmation d’un remboursement des obligations sécurisées Quatrim Paris, le 27 mars 2025 Le Groupe Casino annonce qu’il a procédé, le 27 mars 2026, à un remboursement de 20,8 M€ de la dette...

Repayments confirmation to Quatrim secured bondholders Paris, March 27, 2026 Groupe Casino announces that it has repaid on March 27, 2026, €20.8m of the secured debt carried by its subsidiary...

Dubai and New York, March 27, 2026 — VEON Ltd. (Nasdaq: VEON; “VEON” or the “Company”), a global digital operator, today provided an update underscoring the strong alignment between its management and...